“Ustekinumab Treats Psoriasis by Suppressing RORC and T-Box But Its Suppression of GATA Restrains Its Efficacy”. Brazilian Journal of Pharmaceutical Sciences, vol. 54, no. 4, Dec. 2018, p. e17349, https://doi.org/10.1590/s2175-97902018000417349.